Objective: To explore the effect of Baduanjin combined with cardiopulmonary rehabilitation training on pulmonary function and quality of life in patients with stable chronic obatructive pulmonary disease(COPD). Methods: A total of 80 patients with stable COPD were randomly divided into intervention group and control group, with 40 cases in each group. The control group was given routine medication guidance, smoking prohibition, family oxygen therapy, nutritional diet guidance, and lip contraction abdominal breathing and lung rehabilitation training. The intervention group was subjected to Baduanjin exercise on the basis of the control group, twice a day (once in the morning and once in the evening), twice each time for 12 weeks. Pulmonary function (FVC, FEV1 and FVC/FEV1), dyspnea index score (MMRC), exercise endurance (6MWT) and quality of life (SGRQ) were recorded and compared between the two groups before and 12 weeks after intervention. Results: After 12 weeks of intervention, the values of FVC, FEV1 and FVC/FEV1 in the two groups were significantly higher than those before intervention. The 6MWT in the two groups was significantly higher than that before the intervention (P<0.05), and the MMRC score and SGRQ score were significantly lower than those before the intervention (P<0.05); The 6MWT distance in the intervention group was higher than that in the control group (P<0.05), and the score of MMRC was significantly lower than that in the control group (P<0.05); The SGRQ score in the intervention group was lower than that in the control group (P<0.05). At 6-month follow-up, the scores of MMRC and SGRQ in the two groups were lower than those in the intervention group at 12 weeks, and the scores in the intervention group were significantly lower than those in the control group (P<0.05). Conclusion: Baduanjin combined with cardiopulmonary rehabilitation training is helpful to improve the pulmonary function, reduce the severity of dyspnea, improve the exercise endurance and improve the quality of life of patients with stable COPD. |